Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMARCB1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | ZNF669 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | PROX1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | ATP1A3 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
mRNA | ARHGAP19 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-08 |
mRNA | SCRT2 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | KRI1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | DCUN1D2 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | ZNF565 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-08 |
mRNA | PPP1R32 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |